scispace - formally typeset
B

Bernd Denecke

Researcher at RWTH Aachen University

Publications -  108
Citations -  6450

Bernd Denecke is an academic researcher from RWTH Aachen University. The author has contributed to research in topics: Mesenchymal stem cell & Cellular differentiation. The author has an hindex of 35, co-authored 108 publications receiving 5394 citations. Previous affiliations of Bernd Denecke include Hochschule Hannover.

Papers
More filters
Journal ArticleDOI

Structural basis of calcification inhibition by α2-HS glycoprotein/fetuin-A - Formation of colloidal calciprotein particles

TL;DR: It is demonstrated that precipitation inhibition by Ahsg is caused by the transient formation of soluble, colloidal spheres, containing Ahsg, calcium, and phosphate, which turn progressively more crystalline and insoluble in a time- and temperature-dependent fashion.
Journal ArticleDOI

Surface topography enhances differentiation of mesenchymal stem cells towards osteogenic and adipogenic lineages

TL;DR: This study systematically compared in vitro differentiation of mesenchymal stem cells (MSCs) on a variety of groove/ridge structures to provide further insight into how structuring of tailored biomaterials and implant interfaces do not induce differentiation of MSCs per se, but support their directed differentiation.
Journal ArticleDOI

Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A

TL;DR: Fetuins are serum proteins with diverse functions including the regulation of osteogenesis and inhibition of unwanted mineralization, and the recently identified fetuin-B is a second member of the fetuin family, which belongs to the cystatin superfamily.
Journal ArticleDOI

Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine?

TL;DR: This review provides a comprehensive overview about the construction of exosomes, their targeting and their fusion mechanisms to the recipient cells, and the design of artificial exosome with a clearly defined therapeutic active cargo and surface marker ensuring the specific targeting to the recipients cells is proposed as a promising approach.